Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Traws Pharma (TRAW) Non Operating Income (2016 - 2025)

Traws Pharma's Non Operating Income history spans 14 years, with the latest figure at $14000.0 for Q4 2025.

  • Quarterly results put Non Operating Income at $14000.0 for Q4 2025, up 106.8% from a year ago — trailing twelve months through Dec 2025 was $478000.0 (up 65.4% YoY), and the annual figure for FY2025 was $478000.0, up 65.4%.
  • Non Operating Income for Q4 2025 was $14000.0 at Traws Pharma, down from $96000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $362000.0 in Q1 2023 to a low of -$206000.0 in Q4 2024.
  • The 5-year median for Non Operating Income is $138000.0 (2022), against an average of $139600.0.
  • The sharpest move saw Non Operating Income skyrocketed 31500.0% in 2022, then crashed 174.1% in 2024.
  • Year by year, Non Operating Income stood at -$1000.0 in 2021, then skyrocketed by 31500.0% to $314000.0 in 2022, then decreased by 11.46% to $278000.0 in 2023, then tumbled by 174.1% to -$206000.0 in 2024, then soared by 106.8% to $14000.0 in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $14000.0, $96000.0, and $188000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.